Granulomatous hepatitis associated with carbamazepine therapy

Mack C. Mitchell, John K. Boitnott, Alberto Arregui, Willis C. Maddrey

Research output: Contribution to journalArticle

Abstract

Granulomatous hepatitis developed in two patients while they were receiving carbamazepine (Tegretol®). Both patients had evidence of hepatitis within one month of beginning the drug therapy and had a rapid and complete resolution once the agent was discontinued. In both, the liver biopsy contained granulomas in addition to acute portal inflammation. Carbamazepine should be added to the list of drugs causing granulomatous hepatitis.

Original languageEnglish (US)
Pages (from-to)733-735
Number of pages3
JournalAmerican Journal of Medicine
Volume71
Issue number4
DOIs
StatePublished - 1981
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Mitchell, M. C., Boitnott, J. K., Arregui, A., & Maddrey, W. C. (1981). Granulomatous hepatitis associated with carbamazepine therapy. American Journal of Medicine, 71(4), 733-735. https://doi.org/10.1016/0002-9343(81)90244-8